| Date Filed | Type | Description |
| 04/19/2021 |
GN
| Brilliant Acquisition Corporation: New SEC Guidance Relating to SPAC Warrants, Its Effect on the Company's Periodic Filings and Compliance with Nasdaq Rules |
| 07/20/2020 |
GN
| Brilliant Acquisition Corporation Announces Separate Trading of its Ordinary Shares, Rights, and Warrants, Commencing July 22, 2020 |
| 06/30/2020 |
GN
| Brilliant Acquisition Corporation Announces Full Exercise of Overallotment Option |
| 06/26/2020 |
GN
| Brilliant Acquisition Corporation Announces Closing of $40 Million Initial Public Offering |
| 06/23/2020 |
GN
| BRILLIANT ACQUISITION CORPORATION ANNOUNCES PRICING OF $40 MILLION INITIAL PUBLIC OFFERING |
| 08/20/2015 |
8-K
| Quarterly results |
| 08/20/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/20/2015 |
4
| GRODMAN MARC (President and CEO) has filed a Form 4 on BIO REFERENCE LABORATORIES INC |
| 08/20/2015 |
4
| ROGLIERI JOHN (Director) has filed a Form 4 on BIO REFERENCE LABORATORIES INC|
Txns:
| Disposed/sold 5,000 shares
@ $0 |
|
| 08/20/2015 |
4
| DUBINETT HOWARD (Executive VP, COO) has filed a Form 4 on BIO REFERENCE LABORATORIES INC |
| 08/19/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 08/10/2015 |
8-K
| Other Events |
| 08/06/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 07/30/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 07/17/2015 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 07/02/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 07/02/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 06/18/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 06/11/2015 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 06/11/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 06/10/2015 |
8-K
| Investor presentation |
| 06/10/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 06/10/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 06/08/2015 |
10-Q
| Quarterly Report for the period ended April 30, 2015 |
| 06/08/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 06/08/2015 |
8-K
| Other Events, Financial Statements and Exhibits |
| 06/08/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 06/08/2015 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 06/04/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 06/04/2015 |
8-K
| Acquisition/merger/asset purchase announced|
Docs:
|
"Agreement and Plan of Merger among Bio-Reference Laboratories, Inc., OPKO Health, Inc. and Bamboo Acquisition, Inc",
"Employment Agreement among Bio-Reference Laboratories, Inc., OPKO Health, Inc. and Marc D. Grodman",
"Employment Agreement between Bio-Reference Laboratories, Inc. and Nicholas Papazicos",
"Ehxibit 99.1 OPKO Health to Acquire Bio-Reference Laboratories" |
|
| 06/04/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 06/04/2015 |
425
| Form 425 - Prospectuses and communications, business combinations |
| 05/20/2015 |
8-K
| Entry into a Material Definitive Agreement |
| 04/29/2015 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
|